Macrogen Rises 5.16% Amid Uptrend in Gene Therapy and Analysis Themes

On the 14th, the gene therapy/analysis theme showed strength by rising 4.22% compared to the previous day, with Macrogen, a related stock attracting attention, soaring 5.16% from the previous day. Macrogen is known as a leading company in the fields of gene analysis and DNA chips.

[Graph] Major stock price changes in the gene therapy/analysis theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Macrogen ranked 8th out of 23 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as Macrogen having relatively high investment attractiveness compared to other stocks in the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme


※ The quant financial scores are based on the Robo Algorithm’s analysis of each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.